Advertisement

Picture EBD Group BioTech Showcase 2021 Digital Event BTS2021 651x81
Organisation › Details

Debiopharm (Group)

Debiopharm Group™ is a Swiss-based global biopharmaceutical group of five companies active in the development and manufacture of drugs and diagnostics tools. Debiopharm focuses on developing prescription drugs that target unmet medical needs. The group in-licenses and develops promising drug candidates. The products are commercialized by pharmaceutical out-licensing partners to give access to the largest number of patients worldwide. *

 

Period Start 1979-01-01 established
Product Industry BIOTECH
Person Person Mauvernay, Rolland-Yves (Debiopharm 201301 President + Founder)
     
Region Region Lausanne VD
  Country Switzerland
  Street 5–7 Chemin Messidor
Forum »après-demain«
  City 1002 Lausanne VD
  Tel +41-21-321-0111
    Address record changed: 2020-12-02
     
Basic data Employees n. a.
     
    * Document for �About Section�: Debiopharm International SA. (10/20/16). "Press Release: Debiopharm International SA Announces Clinical Collaboration with the Merck-Pfizer Alliance in Cancer Immunotherapy". Lausanne.
     
   
Record changed: 2020-09-18

Advertisement

Picture ConsulTech GmbH GDPR-compliant E-Col Cloud Document Management 650x80px

More documents for Debiopharm (Group)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Advertisement

Picture EBD Group BioTech Showcase 2021 Whitepaper Presenting 650x80




» top